rilpivirine 2.5 MG (rilpivirine hydrochloride 2.75 MG) Tablet for Oral Suspension

RxCUI: 2678244
RxNorm name: rilpivirine 2.5 MG (rilpivirine hydrochloride 2.75 MG) Tablet for Oral Suspension
Display name: rilpivirine 2.5 MG (rilpivirine hydrochloride 2.75 MG) Tablet for Oral Suspension
Full name: rilpivirine 2.5 MG (rilpivirine hydrochloride 2.75 MG) Tablet for Oral Suspension
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
EDURANT	RILPIVIRINE HYDROCHLORIDE	Janssen Products, LP	03880372-2c68-45c6-a53a-f420c49541d6	2025-08-28	Warnings, Adverse reactions	Exact identifier rxcui: 2678244

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
03880372-2c68-45c6-a53a-f420c49541d6	rilpivirine 2.5 MG (rilpivirine hydrochloride 2.75 MG) Tablet for Oral Suspension	SY	28	These highlights do not include all the information needed to use EDURANT safely and effectively. See full prescribing information for EDURANT. EDURANT ® (rilpivirine) tablets, for oral use EDURANT ® PED (rilpivirine) tablets, for oral suspension Initial U.S. Approval: 2011	20250828
03880372-2c68-45c6-a53a-f420c49541d6	rilpivirine 2.5 MG Tablet for Oral Suspension	SCD	28	These highlights do not include all the information needed to use EDURANT safely and effectively. See full prescribing information for EDURANT. EDURANT ® (rilpivirine) tablets, for oral use EDURANT ® PED (rilpivirine) tablets, for oral suspension Initial U.S. Approval: 2011	20250828
03880372-2c68-45c6-a53a-f420c49541d6	rilpivirine 2.5 MG Tablet for Oral Suspension	PSN	28	These highlights do not include all the information needed to use EDURANT safely and effectively. See full prescribing information for EDURANT. EDURANT ® (rilpivirine) tablets, for oral use EDURANT ® PED (rilpivirine) tablets, for oral suspension Initial U.S. Approval: 2011	20250828